Suppr超能文献

双腔起搏和双异丙吡胺在梗阻性肥厚型心肌病中可能产生的急性和慢性协同作用:病例报告。

Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.

机构信息

Department of Cardiology, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.

出版信息

Eur J Heart Fail. 2010 Jan;12(1):94-7. doi: 10.1093/eurjhf/hfp166. Epub 2009 Nov 25.

Abstract

It remains unclear whether the combination of dual-chamber (DDD) pacing and disopyramide can achieve prolonged left ventricular outflow tract (LVOT) gradient reduction and symptom relief in patients with obstructive hypertrophic cardiomyopathy (HCM). In an HCM patient with a severe LVOT gradient, the combination of DDD pacing and disopyramide achieved marked improvement of gradient in the catheter laboratory and also after medium-term follow-up. The patient's severe dyspnoea was alleviated during the follow-up period. This combination might enable physicians to treat and manage elderly symptomatic obstructive HCM patients with a severe LVOT gradient more effectively and less invasively.

摘要

目前尚不清楚双腔(DDD)起搏和双异丙吡胺联合应用是否能降低梗阻性肥厚型心肌病(HCM)患者的左心室流出道(LVOT)梯度并缓解症状。在一位 LVOT 梯度严重的 HCM 患者中,DDD 起搏和双异丙吡胺联合应用在心导管实验室中以及在中期随访中均显著改善了梯度。在随访期间,患者严重的呼吸困难得到缓解。这种联合治疗可能使医生能够更有效地、非侵入性地治疗和管理老年有症状的梗阻性 HCM 患者伴严重 LVOT 梯度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验